IKang: Endgame Approaching, But Fair Price Is Distant
iKang Healthcare Group (ADR) (KANG US) 's December quarter results provide updated benchmarks for evaluating Yunfeng and Alibaba's US$20/ADS offer...
474 Views
IQIYI IPO: Tencent Video's Metrics Point to a Stronger Business
Comparing iQIYI Inc (IQ US) to its key competitors, Tencent Video and Youku, is a challenge due to lack of financial disclosure from competitors....
434 Views
TRACKING TRAFFIC/Chinese Express & Logistics: January+February Volume Surges, But Is It Sustainable?
Tracking Traffic/Chinese Express & Logistics is the focal point for all our research on China's express parcels and logistics sectors. Tracking...
196 Views
2M 2018 China P2P Lending Review: Sharp Deceleration in New Loan Growth
Industry Review:2.7 trillion RMB of P2P loans were transacted in 2017. Exiting 2017, 1.2 trillion RMB of P2P loans were outstanding. The industry...
165 Views
IQIYI IPO Valuation: Throwing Good Money After Bad
iQIYI Inc (IQ US) is a leading Chinese online video platform. On Friday, it announced its IPO price range of $17-19 per ADS. At the mid-point of...
724 Views